Toxicity-induced Cardiomyopathy in a Patient with Femoral Sarcoma: Heart Transplantation After Support with Ventricular Assist Device as Bridge to Transplantability

Mariano Francisco Del Maria Javier; Eva Maria Javier Delmo; Roland Hetzer

doi:10.1097/MAT.0000000000001496

Toxicity-induced Cardiomyopathy in a Patient with Femoral Sarcoma: Heart Transplantation After Support with Ventricular Assist Device as Bridge to Transplantability

ASAIO J. 2022 Jun 1;68(6):e102-e105. doi: 10.1097/MAT.0000000000001496. Epub 2022 Jul 8.

Authors

Mariano Francisco Del Maria Javier¹, Eva Maria Javier Delmo², Roland Hetzer³

Affiliations

¹ From the Human Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
² Charité Research Organization, Universitätsmedizin Berlin-Charité, Berlin, Germany.
³ Professor in Surgery Charité-Universitätsmedizin Berlin, Germany.

PMID: 34261870
DOI: 10.1097/MAT.0000000000001496

Abstract

This case report exemplifies how a ventricular assist device successfully supported a 15 year old tumor patient with anthracycline-induced cardiomyopathy for 419 days until she was confirmed free from tumor recurrence to undergo heart transplantation, presently with an 18 year follow up without any malignancy.

Publication types

Case Reports

MeSH terms

Adolescent
Cardiomyopathies* / surgery
Female
Heart Failure* / surgery
Heart Transplantation*
Heart-Assist Devices* / adverse effects
Humans
Neoplasm Recurrence, Local
Sarcoma* / complications
Sarcoma* / surgery
Treatment Outcome